PharmaBlock (Stock code: 300725.SZSE) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process and commercial manufacturing. Its dedication to advancing innovation in chemistry and low-carbon manufacturing supports partners to accelerate drug R&D, ensure consistent quality, reduce R&D and manufacturing cost, and foster a greener and more sustainable future.

Officially operated in 2008, PharmaBlock has partnered with almost all the top 20 pharmaceutical companies and hundreds of biotech companies around the world. Its core businesses began with building blocks for drug discovery, and after establishing experience developing robust and scalable processes for manufacturing thousands of compounds, PharmaBlock grew into a research, development & GMP manufacturing service partner for global pharmaceutical and biotech companies.